IPO Boutique

Globus Medical IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Globus Medical, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Globus MedicalGMED -
NYSE
$16.00-$18.00 $12.00 $13.108.33 million8/3/2012
BofA Merrill Lynch, Goldman Sachs, Piper Jaffray
Co-Manager(s):
Leerink Swann, Canaccord Genuity, William Blair, Oppenheimer
Health Care
Filing(s):

Filed 2012-03-28



Globus Medical Quote & Chart - Click for current quote - GMED

About Globus Medical (adapted from Globus Medical prospectus):
They are a medical device company focused exclusively on the design, development and commercialization of products that promote healing in patients with spine disorders.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "GMED" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved